Cerebrolysin
Research chemical — not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.
At a glance
- Best for
- Not established — investigational in the U.S.
- Main caution
- Not FDA-approved; biologically sourced with variable composition and mixed/inconclusive independent evidence
What is it
Cerebrolysin is a peptide preparation derived from purified porcine brain proteins, proposed to have neurotrophic and neuroprotective effects by mimicking the action of nerve growth factors. It is approved and used in several countries (parts of Europe, Asia, and elsewhere) for indications such as stroke and dementia, but it is NOT FDA-approved in the United States, and independent meta-analyses have reached mixed or inconclusive findings about its clinical benefit. As a U.S.-imported 'research' product it is unregulated, and because it is biologically sourced its purity and composition can vary; it is not a dietary supplement and is sold only 'for research use only' domestically.
Is it worth it for you?
Probably skip if…
- You expect a U.S.-approved or clearly proven neurological therapy — it is not FDA-approved and evidence is mixed
- You would source it from 'research use only' vendors with no U.S. regulatory oversight
- You are not prepared for variability inherent to a porcine brain-derived biological product
- You are uncomfortable with self-injection/infusion risks such as infection, hypersensitivity, and contamination
- You want to avoid legal gray areas around importing an unapproved drug
Safety
Common side effects
Reported in clinical use abroad: injection-site reactions, headache, dizziness, sensations of heat/flushing, and (with rapid administration) agitation
Serious risks
- Unregulated supply and variable composition of an animal-sourced biological in the U.S.
- Hypersensitivity/allergic reactions, including the potential for severe reactions
- Theoretical contamination risk from a biologically derived, non-FDA-overseen product
- Mixed/inconclusive independent evidence for the claimed neurological benefits
Who should avoid it
- Anyone using it without direct medical supervision
- Pregnancy and breastfeeding
- People with severe kidney impairment or epilepsy (cautioned in product labeling abroad)
- Anyone with known hypersensitivity to the preparation
Pregnancy & breastfeeding
Avoid — no adequate safety data.
Choosing a product
Be skeptical of
- 'Proven' or 'cure' claims for stroke, dementia, or brain injury (independent evidence is mixed)
- Implying U.S. FDA approval
- Vendors selling imported/'research use only' product for human use without oversight
Track Cerebrolysin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.